logo
Alzheimer's disease therapy: a moving target
Why age (and timing) really matters in developing drugs for neurodegenerative disease
The vasculature in Alzheimer's disease: a new therapeutic target for an old disease?
Epilepsy drug may improve cognitive function in a condition that often leads to Alzheimer's disease
New Alzheimer's drug in Phase I clinical trials may target both amyloid and tau pathology
New guidelines available for genetic counseling and testing for Alzheimer's disease
Brain imaging shows promise for detecting amyloid burden in Alzheimer's disease
Combination therapy may provide cognitive benefit to Alzheimer's patients
Amyloid fibrils, oligomers, dimers…
A way to look at tangles in vivo
Amyloid could not be enough
Interview: Alzheimer's disease: new paradigms for neurologists
Pathological phenotype in familial neurodegenerative disease: implications for families and therapeutic constructs
Repositioning leptin as a therapy for Alzheimer's disease
Current and future treatments of memory complaints and Alzheimer's disease
Progenitor cell therapies as a novel treatment for traumatic brain injury: a pathway towards neuroprotection
Breathe easy? Exhaled molecules may reveal those who have been infected with influenza
Initiation of in-patient clinical trials with a novel oral therapy for multiple sclerosis
Transcatheter heart valve receives positive opinion from the US FDA
Promising preliminary short-term pharmacokinetic and glucodynamic effectiveness demonstrated by a novel inhaled insulin formulation
ISENTRESS (raltegravir) demonstrates efficacy in combination therapy during 5-year extended Phase II study in previously untreated patients with HIV-1
Review of pantoprazole in pediatrics
Tenofovir in the treatment of chronic hepatitis B
Comparison of the therapeutic efficacy of 0.1% olopatadine hydrochloride and 0.025% ketotifen fumarate in allergic conjunctivitis
Rebound tonometry for the measurement of intraocular pressure and its relation with gender and refractive errors in Mozambique
Antimalarial drug combination chemotherapy in malaria case management in Tanzania: how did it come about?
The spectrum of albuminuria as a predictor of cardiorenal outcomes
Acknowledgements